Bayer Beats FCA Suit Over Off-Label Yaz Marketing

Law360, New York (September 5, 2012, 1:21 PM EDT) -- A Texas federal judge on Friday tossed a lawsuit alleging Bayer Schering Pharma AG defrauded Medicaid by touting off-label uses for contraceptive drugs Yasmin and Yaz, saying a supposed whistleblower was not the original source of the claims because they were previously reported by Law360 and other news outlets.

U.S. District Judge Marcia A. Crone granted Bayer’s April 16 motion to dismiss the False Claims Act suit by Pharma Fraud Watch LLC. The group claimed Bayer caused doctors to seek Medicaid reimbursements for off-label prescriptions of...
To view the full article, register now.